oNKo-innate is a discovery-stage biotechnology company dedicated to target identification and pre-clinical immuno-oncology drug development. With our deep understanding of Natural Killer (NK) cells, we aim to be the first to truly therapeutically harness the cancer-fighting abilities of these remarkable white blood cells.

Pharmaceutical

Biotechnology

oNKo-innate

Jai Rautela

Nicholas Huntington

Joe Cursons

The Leadership Team at oNKo-innate guides the strategic direction and vision of the company, focusing on innovative approaches to immuno-oncology drug development. Comprising the Co-founder & CEO, Principal Scientist, and Co-founder & CSO, the team leverages their expertise in Natural Killer (NK) cell biology to oversee research initiatives, foster collaborations, and drive the advancement of the company's therapeutic portfolio.

Leadership Team

About

Team members

Other teams at oNKo-innate

Research and Development